Crombez Eric — SEC Form 4 filings
SEC reporting owner CIK 1653052. 14 Form 4 filings on record with FilingPulse; latest filed 2026-05-15.
Transaction summary — filings shown
Covers all 14 filings on record, filed 2024-03-05 to 2026-05-15. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 11 legs across 10 filings — 65,959 shares, $922,821 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 12.
- Largest priced transaction: sale of 8,945 shares @ $42.10 ($376,584) in Ultragenyx Pharmaceutical Inc., filed 2025-03-04.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. (RARE) | EVP and Chief Medical Officer | 8 | — | 8 legs · 18,814 sh · $662,606 | 9 |
| ABEONA THERAPEUTICS INC. (ABEO) | Director | 6 | — | 3 legs · 47,145 sh · $260,214 | 3 |
Form 4 filings — Crombez Eric
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-15 | 4 | ABEONA THERAPEUTICS INC. (ABEO) | Sale (S): 26,143 @ $5.53 | EDGAR |
| 2026-05-06 | 4 | Ultragenyx Pharmaceutical Inc. (RARE) | Sale (S): 344 @ $24.96 | EDGAR |
| 2026-04-20 | 4 | Ultragenyx Pharmaceutical Inc. (RARE) | Grant/award (A): 34,674 @ $0 · Grant/award (A): 59,952 (derivative) @ $0 | EDGAR |
| 2026-03-03 | 4 | Ultragenyx Pharmaceutical Inc. (RARE) | Grant/award (A): 11,643 @ $0 · Sale (S): 7,029 @ $22.80 | EDGAR |
| 2026-02-02 | 4 | ABEONA THERAPEUTICS INC. (ABEO) | Sale (S): 16,284 @ $5.09 | EDGAR |
| 2026-01-27 | 4 | ABEONA THERAPEUTICS INC. (ABEO) | Grant/award (A): 37,313 @ $0 | EDGAR |
| 2025-08-15 | 4 | ABEONA THERAPEUTICS INC. (ABEO) | Sale (S): 4,718 @ $6.93 | EDGAR |
| 2025-05-05 | 4 | Ultragenyx Pharmaceutical Inc. (RARE) | Sale (S): 242 @ $35.11 · Sale (S): 520 @ $39.24 | EDGAR |
| 2025-03-04 | 4 | Ultragenyx Pharmaceutical Inc. (RARE) | Grant/award (A): 16,813 @ $0 · Grant/award (A): 14,971 @ $0 · Sale (S): 8,945 @ $42.10 · Grant/award (A): 30,246 (derivative) @ $0 | EDGAR |
| 2025-02-03 | 4 | ABEONA THERAPEUTICS INC. (ABEO) | Grant/award (A): 36,101 @ $0 | EDGAR |
| 2024-08-14 | 4 | ABEONA THERAPEUTICS INC. (ABEO) | Grant/award (A): 11,044 @ $0 | EDGAR |
| 2024-05-03 | 4 | Ultragenyx Pharmaceutical Inc. (RARE) | Sale (S): 354 @ $43.66 | EDGAR |
| 2024-04-19 | 4 | Ultragenyx Pharmaceutical Inc. (RARE) | Sale (S): 142 @ $44.10 | EDGAR |
| 2024-03-05 | 4 | Ultragenyx Pharmaceutical Inc. (RARE) | Grant/award (A): 19,400 @ $0 · Sale (S): 1,238 @ $53.76 · Grant/award (A): 34,200 (derivative) @ $0 · Grant/award (A): 2,351 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1653052 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →